Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

被引：0
|
作者：
Nobuyuki Amemiya
Takashi Takei
Chiari Kojima
Hirohiko Nokiba
Mitsuyo Itabashi
Kosaku Nitta
机构：
[1] Tokyo Women’s Medical University,Department of Medicine, Kidney Center
来源：
Clinical and Experimental Nephrology | 2011年 / 15卷
关键词：
Frequently relapsing minimal change nephrotic syndrome; Rituximab; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment with a single dose of rituximab alone induced remission in a patient with relapsed minimal change nephrotic syndrome (MCNS). A 27-year-old man was given corticosteroid (prednisolone; PSL) and cyclosporine (CyA) therapy combined with rituximab for his fifth relapse in 2008. Thereafter, complete remission was achieved and maintained despite eventual discontinuation of the PSL and CyA. In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS.
引用
收藏
页码：933 / 936
页数：3
相关论文
共 50 条
  • [21] Relapsing nephrotic syndrome in a diabetic patient with minimal change
    Donaire, JAG
    Manzanera, MJ
    Valentín, MO
    Espejo, B
    Martínez, EG
    Praga, M
    NEFROLOGIA, 2004, 24 (02): : 179 - 182
  • [22] Remission of refractory minimal change nephrotic syndrome after basiliximab therapy
    Sung-Shin Park
    Won-Ho Hahn
    Sung-Do Kim
    Byoung-Soo Cho
    Pediatric Nephrology, 2009, 24 : 1403 - 1407
  • [23] EARLY AND SPONTANEOUS COMPLETE REMISSION OF MINIMAL CHANGE NEPHROTIC SYNDROME IN ADULTS
    ARAQUE, A
    PRAGA, M
    MAZUECOS, A
    ORTUNO, T
    ALCAZAR, JM
    SANCHEZ, R
    ANDRES, A
    RODICIO, JL
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 562 - 562
  • [24] Remission of refractory minimal change nephrotic syndrome after basiliximab therapy
    Park, Sung-Shin
    Hahn, Won-Ho
    Kim, Sung-Do
    Cho, Byoung-Soo
    PEDIATRIC NEPHROLOGY, 2009, 24 (07) : 1403 - 1407
  • [25] Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
    Usui, Ryosuke
    Tsuchiya, Yohei
    Nitta, Kosaku
    Koike, Minako
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2018, 8 (03): : 230 - 237
  • [26] A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab
    Yoshida, Ryuto
    Hara, Yoshikazu
    Fujii, Yoshiaki
    Matuda, Hiroto
    CEN CASE REPORTS, 2023, 12 (04) : 368 - 373
  • [27] A case of minimal change nephrotic syndrome complicated by Kimura disease treated with rituximab
    Ryuto Yoshida
    Yoshikazu Hara
    Yoshiaki Fujii
    Hiroto Matuda
    CEN Case Reports, 2023, 12 : 368 - 373
  • [28] Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination
    Kielstein, JT
    Termühlen, L
    Sohn, J
    Kliem, V
    CLINICAL NEPHROLOGY, 2000, 54 (03) : 246 - 248
  • [29] Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy
    Kobayashi, T.
    Ando, Y.
    Umino, T.
    Miyata, Y.
    Muto, S.
    Hironaka, M.
    Asano, Y.
    Kusano, E.
    CLINICAL NEPHROLOGY, 2006, 65 (06) : 423 - 426
  • [30] DNA methylation changes between relapse and remission of minimal change nephrotic syndrome
    Kobayashi, Yasuko
    Aizawa, Akira
    Takizawa, Takumi
    Yoshizawa, Chikage
    Horiguchi, Hiromi
    Ikeuchi, Yuka
    Kakegawa, Satoko
    Watanabe, Toshio
    Maruyama, Kenichi
    Morikawa, Akihiro
    Hatada, Izuho
    Arakawa, Hirokazu
    PEDIATRIC NEPHROLOGY, 2012, 27 (12) : 2233 - 2241
12345